MassDevice.com +3 | The top 3 medtech stories for October 14, 2015

Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.   3. HeartFlow’s CT-based FFR lowers costs, improves quality of life A non-invasive test of cardiac function made by HeartFlow lowered the cost of care and delivered improved quality of life scores compared to standard care, according to a study presented at the annual Transcatheter Cardiovascular Therapeutics conference. HeartFlow’s FFRCT test uses data from a standard CT scan to create a 3D map of the changes in blood flow as it passes across a coronary lesion. Results from the 584-patient Platform trial showed that the costs associated with planned angiography and the FFRCT procedure were 32% lower than the cost of angiography alone ($7,343 vs. $10,734). Read more 2. SynCardia pulls $28m IPO SynCardia Systems withdrew its plans for an initial public offering that was slated to fetch $27.5 million at the midpoint. “The registrant submits this request for withdrawal as it does not intend to pursue the contemplated public offering at this time,” the Tucson-based artificial heart maker said in an SEC filing. Syncardia had planned to float 2.5 million shares at $10 to $12 apiece. Read more 1. AtriCure closes $99m n...
Source: Mass Device - Category: Medical Equipment Authors: Tags: News Well Plus 3 Source Type: news

Related Links:

We present a 68-year-old woman who was undergoing treatment for recurrent urinary tract infection (UTI) but was incidentally noted to be dyspneic and intermittently hypoxic. She was found to have idiopathic pulmonary vein thrombosis that was successfully managed with systemic anticoagulation.
Source: Respiratory Medicine Case Reports - Category: Respiratory Medicine Source Type: research
CONCLUSION: Cardiac rehabilitation, along with moderate and regular physical activity, has been proven to reduce the time in arrhythmia of patients with paroxysmal and persistent AF. In chronic AF, cardiac rehabilitation may decrease the resting ventricular response rate in patients and therefore improve symptoms linked to arrhythmia. These studies have managed to demonstrate cardiac rehabilitation as a safe and manageable option for AF patients, without serious risk of additional side effects. Its efficiency to limit the occurrence of serious undesirable outcomes, such as mortality and hospitalisation, has not been adequa...
Source: Acta Cardiologica - Category: Cardiology Tags: Acta Cardiol Source Type: research
This study aimed to investigate the incidence of atrial fibrillation (AF) and its prognosis in the patients after dialysis initiation. METHODS: A total of 1524 patients with chronic kidney disease who were initiated on dialysis were included. Dialysis was initiated between October 2011 and September 2013. Electrocardiogram was obtained at dialysis initiation, in March 2015, and September 2016. The mortality and cardiovascular disease (CVD) event rates of 1520 patients (1028 men and 492 women; mean age, 67.5 ± 13.1 years) who were followed up were compared, and they were divided into 2 groups: the AF group (...
Source: Acta Cardiologica - Category: Cardiology Tags: Acta Cardiol Source Type: research
AbstractBackgroundDigitalis glycosides are employed for rate control of atrial fibrillation. Recent studies suggested potential harmful effects of digitalis monotherapy and combination with antiarrhythmic drugs. The aim of the present study was to assess the prevalence and potential impact of digitalis therapy on outcome in patients undergoing catheter ablation of supraventricular arrhythmias.Methods and resultsThe German Ablation Registry is a nationwide, prospective registry with a 1-year follow-up investigating 12,566 patients receiving catheter ablations of supraventricular arrhythmias in 52 German centres. The present...
Source: Clinical Research in Cardiology - Category: Cardiology Source Type: research
AbstractPurposeTo investigate inpatient prevalence, expenditures, and comorbidities of hospitalized patients with sarcoidosis in the USA.MethodsPatients with sarcoidosis were identified within the Nationwide Inpatient Sample (NIS) database for the years 2013 and 2014 using the respective ICD-9 diagnostic code. Data on patient and hospital characteristics, comorbidities, total hospital costs, and total hospitalization charges were collected. A propensity-matched cohort of patients without sarcoidosis from the same database was created and used as comparators for the analysis of comorbidities.ResultsA cohort of 78,055 patien...
Source: Lung - Category: Respiratory Medicine Source Type: research
Publication date: Available online 21 February 2019Source: Canadian Journal of CardiologyAuthor(s): Marco Proietti, Deirdre A. Lane, Giuseppe Boriani, Gregory Y.H. LipAbstractIn recent years the management of AF patients has progressively and substantially changed due to the introduction of new treatments and the availability of new data regarding the epidemiology and clinical management of these patients. In the last two years alone, there have been seven new guidelines or guideline updates that have been published, introducing new recommendations and significantly revising previously published ones. Two updates for Canad...
Source: Canadian Journal of Cardiology - Category: Cardiology Source Type: research
(University of Minnesota Medical School) Lin Yee Chen, MD, MS, Associate Professor with Tenure, Cardiovascular Division, in the Department of Medicine with the University of Minnesota Medical School was part of a Writing Committee tasked with updating the 2014 guidelines for patients with AFib. The 2019 American College of Cardiology/American Heart Association/Heart Rhythm Society Guidelines for the Management of Patients with Atrial Fibrillation were just published as the standard for the management of Afib in the U.S.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
Approximately 7% of patients undergoing percutaneous coronary intervention (PCI) with stent implantation have atrial fibrillation. The optimal antithrombotic treatment in such of patients remains one of the most challenging and difficult scenarios in Cardiology. Triple antithrombotic therapy (TAT), consisting of dual antiplatelet therapy plus an oral anticoagulant, has been used for decades in order to reduce ischemic and thromboembolic events, while significantly increasing the risk for severe bleeding.
Source: Thrombosis Research - Category: Hematology Authors: Tags: Short Review Source Type: research
Journal of Cardiovascular Electrophysiology, EarlyView.
Source: Journal of Cardiovascular Electrophysiology - Category: Cardiology Authors: Tags: EP IMAGE Source Type: research
The objectives of the CONSIDER AF (NCT02877745) observational study are to evaluate the impact of sleep-disordered breathing (SDB) on the rate of major adverse cardiac and cerebrovascular events in patients undergoing elective coronary artery bypass grafting (CABG) surgery. In addition, explorative analyses will allow specification of subgroups of patients with SDB with the highest risk for peri- and postoperative complications.MethodsCONSIDER AF is a  single-center study in patients with and without SDB undergoing elective CABG. The presence and type of SDB are assessed the night prior to CABG using portable SDB moni...
Source: Somnologie - Schlafforschung und Schlafmedizin - Category: Sleep Medicine Source Type: research
More News: Angiography | Atrial Fibrillation | Cardiology | Cardiovascular | Conferences | CT Scan | Health | Heart | Heart Transplant | Medical Devices | Perfusion | PET Scan | Study